West Pharmaceutical Services (WST) Stock Forecast & Price Target

West Pharmaceutical Services
Bull Case

Here are some ways that investors could benefit from investing in West Pharmaceutical Services, Inc.:

• West Pharmaceutical Services, Inc. recently reported third-quarter earnings that significantly exceeded market expectations, with actual earnings per share of $2.66 beating the consensus estimate of $2.20 by $0.46, demonstrating strong operational performance and profitability that can drive shareholder value.
• The company has raised its full-year 2026 earnings outlook following its strong third-quarter results, signaling management confidence in continued growth and providing a clearer path for investors to anticipate higher future profits compared to previous estimates.
• Wall Street analysts have recently increased their price targets for the stock, with Barclays raising its target to $500.00 and Jefferies Financial Group setting a target of $475.00, reflecting a consensus view that the current valuation may not fully capture the company's growth potential.
• West Pharmaceutical Services, Inc. recently increased its quarterly dividend to $0.26 per share, representing a positive change from the previous $0.22 payout and offering investors a growing income stream that supports total return alongside capital appreciation.
• The stock is currently trading at $411.77, which is well above its 200-day moving average of $317.40, indicating strong momentum and sustained investor interest that often correlates with continued upward price trends in the near term.